Ovid Therapeutics Outlines 2019 Clinical and Business Priorities
— OV101 in Angelman syndrome: Pivotal Phase 3 NEPTUNE trial expected to begin in second half 2019 — — OV101 […]
— OV101 in Angelman syndrome: Pivotal Phase 3 NEPTUNE trial expected to begin in second half 2019 — — OV101 […]
TORONTO, Jan. 04, 2019 (GLOBE NEWSWIRE) — Last month, Canada House Wellness Group Inc. (“Canada House” or the “Company”) was […]
VANCOUVER, British Columbia, Jan. 04, 2019 (GLOBE NEWSWIRE) — Declan Cobalt Inc. (“Declan” or the “Company“) (CSE: LAN) (FSE: DCR1) […]
VANCOUVER, British Columbia, Jan. 04, 2019 (GLOBE NEWSWIRE) — The Yield Growth Corp. (CSE:BOSS) announces that it has engaged Incanco […]
SUNNYVALE, Calif., Jan. 04, 2019 (GLOBE NEWSWIRE) — Ooma, Inc., a smart communications platform for businesses and consumers, today announced […]
ALAMEDA, Calif., Jan. 04, 2019 (GLOBE NEWSWIRE) — BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative […]
Andrew Harrison Promoted to President & COO NEW YORK, Jan. 04, 2019 (GLOBE NEWSWIRE) — Harte Hanks (NYSE: HHS), a […]
METTAWA, Ill., Jan. 04, 2019 (GLOBE NEWSWIRE) — Brunswick Corporation (NYSE: BC) today added its voice in praise of marine […]
ISELIN, N.J., Jan. 04, 2019 (GLOBE NEWSWIRE) — Provident Financial Services, Inc. (NYSE: PFS) announced that it expects to release […]
NEW YORK, Jan. 04, 2019 (GLOBE NEWSWIRE) — Tyme Technologies, Inc. (NASDAQ:TYME), a clinical-stage oncology company developing metabolically-based cancer therapeutics, today […]